Abstract:Remifentanil appears to be a comparable opioid to fentanyl when supplementing isoflurane/nitrous oxide anaesthesia for carotid endarterectomy.
“…This observation is in accord with the results of previous investigations after carotid artery operations [5,6]. In evaluating patient recovery using the Aldrete scale 15 and 60 minutes after the end of surgery, no differences were noted between the 2 groups.…”
Section: Discussionsupporting
confidence: 92%
“…The dose regimen for remifentanil in the present study is higher than the regimen used by previous investigators in carotid artery surgery [5,6], but it has been effectively administered by other authors [18,19]. It was chosen to investigate remifentanil's ability to reduce intraoperative hypertensive events.…”
Section: Discussionmentioning
confidence: 97%
“…Remifentanil is a l-opioid receptor agonist that has potency similar to that of fentanyl and systemic half-life approximately 9 to 11 minutes, which allows rapid emergence from anesthesia even after prolonged infusions [1][2][3]. However, it is not clear whether remifentanil is superior to fentanyl as far as intraoperative hemodynamic stability and recovery characteristics after carotid endarterectomy are concerned [4][5][6].…”
“…This observation is in accord with the results of previous investigations after carotid artery operations [5,6]. In evaluating patient recovery using the Aldrete scale 15 and 60 minutes after the end of surgery, no differences were noted between the 2 groups.…”
Section: Discussionsupporting
confidence: 92%
“…The dose regimen for remifentanil in the present study is higher than the regimen used by previous investigators in carotid artery surgery [5,6], but it has been effectively administered by other authors [18,19]. It was chosen to investigate remifentanil's ability to reduce intraoperative hypertensive events.…”
Section: Discussionmentioning
confidence: 97%
“…Remifentanil is a l-opioid receptor agonist that has potency similar to that of fentanyl and systemic half-life approximately 9 to 11 minutes, which allows rapid emergence from anesthesia even after prolonged infusions [1][2][3]. However, it is not clear whether remifentanil is superior to fentanyl as far as intraoperative hemodynamic stability and recovery characteristics after carotid endarterectomy are concerned [4][5][6].…”
“…with a regional technique). Clinically, remifentanil titratability translates into a better control over adrenergic stimuli whatever the type of surgery or the patients (Kapila et al 1995;Mouren et al 2001;Schuttler et al 1997;Cartwright et al 1997;Gemma et al 2002;Guy et al 1997;Howie et al 2001;McGregor et al 1998;Sneyd et al 2001;Ahonen et al 2000;Balakrishnan et al 2000;Casati et al 2000;Doyle et al 2001;Fleisher et al 2001;Natalini et al 1999;Twersky et al 2001;Wee et al 1999;Wilhelm et al 2001). For example, intubation is a stronger stimulus than laryngoscopy, which in turn is stronger than skin incision.…”
Section: Control Over Intra-operative Stimulimentioning
Most opioids used in anaesthesia are of the anilidopiperidine family, including fentanyl, alfentanil, sufentanil and remifentanil. While all share similar pharmacological properties, remifentanil, the newest one, is probably the most original, which is the reason this review focusses especially on this drug. Remifentanil is a potent mu-agonist that retains all the pharmacodynamic characteristics of its class (regarding analgesia, respiratory depression, muscle rigidity, nausea and vomiting, pruritus, etc.) but with a unique pharmacokinetic profile that combines a short onset and the fastest offset, independent of the infusion duration. Consequently, it offers a unique titratability when its effects need to be quickly achieved or suppressed, but it requires specific drug delivery schemes such as continuous infusion, target-controlled infusion and anticipated postoperative pain treatment. Kinetic differences between opioids used in anaesthesia and some clinical uses of remifentanil are reviewed in this chapter.
“…Am schnellsten ist die neurologische Beurteilbarkeit nach Remifentanil zu erreichen. In Bezug auf hämo-dynamische Stabilität oder postoperative Übelkeit zeigten sich keine Unterschiede zwischen Fentanyl, Sufentanil und Remifentanil [24,62]. De Castro et al [22] untersuchten die Hämodynamik in Abhängigkeit von der Art der Remifentanilapplikation.…”
Carotid endarterectomy (CEA) has remained the first choice of treatment in preventing ischemic stroke due to symptomatic stenosis of the internal carotid artery despite other new available options. During CEA patients are first and foremost at risk of cerebral as well as myocardial ischemia, therefore, maintenance of the oxygen supply to the brain and the myocardium is of outstanding importance requiring reliable monitoring of cerebral and cardiac function. The regional versus general anesthesia debate is an age-old one that has brought few definite answers regarding the impact on postoperative outcome of either anesthetic technique. Up to now, there is little evidence from only a few randomized clinical trials to demonstrate the superiority of either anesthetic technique with respect to outcome parameters. Because the level of evidence in favor of regional anesthesia during CEA can at least be rated between 1(-) and 2(+) the resulting recommendation is grade C. The purpose of the review is to highlight the characteristics and goals of anesthetic management during CEA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.